Clinical trial
Prospective Observational Study of Perioperative Biomarkers and Outcomes in Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction
NCT07263347 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study of Perioperative Biomarkers and Outcomes in Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction
- Lead sponsor
- Hubei Cancer Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 20, 2025
- Completion date
- October 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasms, inflammation, ischemia-reperfusion injury, oxidative stress, postoperative complications, wound healing